期刊文献+

培美曲塞联合顺铂治疗非小细胞肺癌临床疗效观察 被引量:12

下载PDF
导出
摘要 目的观察培美曲塞联合顺铂治疗非小细胞肺癌临床疗效。方法将2010年3月-2013年1月湖南省双峰县中医院收治的100例非小细胞肺癌患者随机分为观察组(n=50)和对照组(n=50),观察组患者采用培美曲塞联合顺铂治疗,对照组患者采用吉西他滨联合顺铂治疗。结果观察组患者的治疗有效率和疾病控制率显著地优于对照组患者(P<0.05),并且两组患者的毒副反应无统计学意义。结论培美曲塞联合顺铂治疗非小细胞肺癌疗效确切,具有协同加强作用,值得临床推广应用。
作者 朱赣湘
出处 《当代医学》 2014年第6期150-151,共2页 Contemporary Medicine
  • 相关文献

参考文献8

二级参考文献37

  • 1李树婷,马飞,孙燕.抗肿瘤代谢新药——培美曲塞[J].癌症进展,2005,3(5):471-476. 被引量:73
  • 2刘联,王秀问,黎莉,张昕,张文东,于学军.含顺铂的三组联合化疗方案治疗晚期非小细胞肺癌的随机对照临床研究[J].癌症,2006,25(8):990-994. 被引量:93
  • 3王莉.培美曲塞治疗非小细胞肺癌[J].癌症进展,2006,4(5):440-443. 被引量:10
  • 4Gridelli C, Perrone F, Monfardini S. Lung cancer in the elderly[ J]. Eur J Cancer, 1997,33 (14) :2313-2314.
  • 5Han K, Cao W, Che J, et al. First line chemotherapy with weekly docetaxel and cisplatin in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study[J]. J Thorac Oncol, 2009, 4(4) :512-517.
  • 6Tibaldi C, Vasile E, Antonuzzo A, et al. First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients : a multicenter phase II study [ J ]. Br J Cancer, 2008,98 ( 3 ) :558-563.
  • 7Giorgio CG, Pappalardo A, Russo A, et al. A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) [ J ]. Lung Cancer, 2006, 51 ( 3 ) :357-362.
  • 8Pujol JL, Paul S, Chouaki N, et al. Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC) : a risk-benefit analysis[J]. J Thorac Oncol, 2007, 2(5) :397-401.
  • 9Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase Ⅲ trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy[J]. J Clin Oncol, 2004, 22(9) :1589-1597,.
  • 10Kulkarni PM, Chen R, Anand T, et al. Efficacy and safety of pemetrexed in elderly cancer patients: results of an integrated analysis [ J ]. Crit Rev Oncol Hematol, 2008, 67 (1): 64-70.

共引文献102

同被引文献76

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部